Decreased lipases and fatty acid and glycerol transporter could explain reduced fat in diabetic morbidly obese

Obesity

Volumn 22, Issue 11, 2014, Pages 2379-2387

  Ferrer, Roser ^a   Pardina, Eva ^b   Rossell, Joana ^b   Baena Fustegueras, Juan Antonio ^c   Lecube, Albert ^d   Balibrea, José María ^a   Caubet, Enric ^a   González, Oscar ^a   Vilallonga, Ramón ^a   Fort, Jose Manuel ^a   Peinado Onsurbe, Julia ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital de Arnau de Vilanova   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AQUAPORIN 7; CD36 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID BINDING PROTEIN 4; GLUCOSE TRANSPORTER 4; HORMONE SENSITIVE LIPASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; LIPID; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 2; ANTIGENS, CD36; AQP7 PROTEIN, HUMAN; AQUAPORINS; FABP4 PROTEIN, HUMAN; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; GLUCOSE TRANSPORTER TYPE 4; GLYCEROL; LIPASE; LPL PROTEIN, HUMAN; PNPLA2 PROTEIN, HUMAN; SLC2A4 PROTEIN, HUMAN; STEROL ESTERASE;

ADIPONECTIN GENE; ADULT; AQ7 GENE; ARTICLE; ATGL GENE; BLOOD SAMPLING; CD36 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; DOWN REGULATION; DYSLIPIDEMIA; ENOS3 GENE; ENZYME ACTIVITY; FAPB4 GENE; FEMALE; GENE; GENE EXPRESSION; GLUT4 GENE; HSL GENE; HUMAN; HUMAN TISSUE; HYPERTENSION; IL 6 GENE; INOS2 GENE; INSR GENE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEPTIN GENE; LIPID METABOLISM; LIPID STORAGE; LPL GENE; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAI 1 GENE; PPAR DELTA GENE; PPAR GAMMA GENE; PPARGC1 ALPHA GENE; PROTEIN EXPRESSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; SUBCUTANEOUS FAT; TNF ALPHA GENE; UCP2 GENE; ADIPOSITY; BIOLOGICAL TRANSPORT; COMPLICATION; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; DYSLIPIDEMIAS; GENETICS; HUMANS; INTRA-ABDOMINAL FAT; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PATHOLOGY; YOUNG ADULT;

ADIPOSITY; ADULT; ANTIGENS, CD36; AQUAPORINS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; DYSLIPIDEMIAS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; GLUCOSE TRANSPORTER TYPE 4; GLYCEROL; HUMANS; INTRA-ABDOMINAL FAT; LIPASE; LIPID METABOLISM; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; OBESITY, MORBID; STEROL ESTERASE; SUBCUTANEOUS FAT; YOUNG ADULT;

EID: 84911006623     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20861     Document Type: Article

References (37)

1. Wajchenberg BL, Lerario AC, Giannella ND, Rocha MS. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Int J Obes 2000;21:697-738.
2. Marin P, Gustafsson C, Oden B, Holm G, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 1994;80:239-243.
3. Kern PA, Ong JM, Saffari B, Carty J. The effects of weight loss on the activity and expression of adipose-tissue lipoprotein lipase in very obese humans. N Engl J Med 1990;322:1053-1059.
4. Groop L. Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion. Int J Clin Pract 2000;113:3-13.
5. Mairal A, Langin D, Arner P, Hoffstedt J. Human adipose triglyceride lipase (PNPLA2) is not regulated by obesity and exhibits low in vitro triglyceride hydrolase activity. Diabetologia 2006;49:1629-1636.
6. Meisner H, Tenney K. pH as an indicator of free fatty acid release from adipocytes. J Lipid Res 1977;18:774-776.
7. Bulló M, Salas-Salvado J, Garcia-Lorda P. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obes Surg 2005;15:382-386.
8. Claus TH, Lowe DB, Liang Y, et al. Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose. J Pharmacol Exp Ther 2005;315:1396-1402.
9. Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Arner P. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest 1994;93:2590-2599.
10. Large V, Reynisdottir S, Langin D, et al. Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 1999;40:2059-2066.
11. Kolehmainen M, Vidal H, Ohisalo JJ, Pirinen E, Alhava E, Uusitupa M. Hormone sensitive lipase expression and adipose tissue metabolism show gender difference in obese subjects after weight loss. Int J Obes 2000;26:6-16.
12. Frayn KN, Coppack SW, Fielding BA, Humphreys SM. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul 1977;35:163-178.
13. Belfrage P, Fredrickson DS, Gudrun C, Nilsson A, Osten N, Stralfors P. Hormone-sensitive lipase of rat adipose tissue. INSERM 1979;87:161-178.
14. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes 2010;34:S18-S23.
15. Pataky Z, Bobbioni-Harsch E, Makoundou V, Golay A. What is the evolution of metabolically normal obesity? Rev Med Suisse 2011;7:692-694.
16. Barbarroja N, Lopez-Pedrera R, Mayas MD, et al. The obese healthy paradox: is inflammation the answer? Biochem J 2010;430:141-149.
17. Pardina E, Ferrer R, Baena-Fustegueras JA, et al. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight loss in the morbidly obese. Obes Surg 2010;20:623-632.
18. NCEP. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Jr Am Med Assoc 2001;285:2486-2497.
19. Standardization of anthropometric measurements: The Airlie (VA). Consensus Conference. Champaign, Human Kinetics Publishers, 1988, pp 20-37.
20. Briquet-Laugier V, Ben-Zeev O, Doolittle MH. Determining lipoprotein lipase and hepatic lipase activity using radiolabeled substrates. Methods Mol Biol 1999;109:81-94.
21. Ballart X, Siches M, Peinado-Onsurbe J, et al. Isoproterenol increases active lipoprotein lipase in adipocyte medium and in rat plasma. Biochimie 2003;85:971-982.
22. McCoy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 2002;43:921-929.
23. Ramírez I, Severson DL. Effect of diabetes on acid and neutral triacylglycerol lipase and on lipoprotein lipase activities in isolates myocardial cells from rat heart. Biochem J 1986;238:233-238.
24. Stam H, Hülsmann WC. Comparison of heparin-releasable lipase and tissue neutral lipase activity of rat heart. Biochem Int 1983;7:187-195.
25. Rodriguez-Sureda V, Peinado-Onsurbe J. A procedure for measuring triacylglyceride and cholesterol content using a small amount of tissue. Anal Biochem 2005;343:277-282.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
27. Vytasek R. A sensitive fluorometric assay for the determination of DNA. Anal Biochem 1982;120:243-248.
28. Wildman RP, Kaplan R, Manson JE, et al. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study. Obesity 2011;19:1482-1491.
29. Aguilar-Salinas CA, Garcia EG, Robles L, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008;93:4075-4079.
30. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150.
31. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
32. Immonen H, Hannukainen JC, Iozzo P, et al. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients. J Hepatol 2014;60:377-383.
33. Miranda M, Ceperuelo-Mallafre V, Lecube A, et al. Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities. Metabolism 2009;58:1762-1768.
34. Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Int J Obes 2006;30:877-883.
35. Terra X, Quintero Y, Auguet T, et al. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. Eur J Endocrinol 2011;164:539-547.
36. Ramis JM, Bibiloni B, Moreiro J, et al. Tissue leptin and plasma insulin are associated with lipoprotein lipase activity in severely obese patients. J Nutr Biochem 2005;16:279-285.
37. Casanovas A, Carrascal M, Abian J, Lopez-Tejero MD, Llobera M. Lipoprotein lipase is nitrated in vivo after lipopolysaccharide challenge. Free Radic Biol Med 2009;47:1553-1560.